शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MANIPALHOSBSEMANIPAL HEALTH ENTERPRI LHighNegative
Announced Fri, 4 Sept, 2026 · 10:27 IST

Promoter encumbrance disclosure under SAST Reg 31(1)

MANIPALHOS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹726.20
prior close
₹730.70
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-1.0% vs market

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.5
15m
+0.3
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-0.3+0.7-1.0
Next day
-0.3+1.1-1.4
2d
-1.2+1.6-2.8
3d
+0.5+1.5-1.0
4d
+0.7+1.3-0.6
5d
-1.3+1.4-2.6
1w
-1.7-2.1+0.4
15d
-0.6-0.9+0.3
1m
-8.2-1.4-6.7
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoters of Manipal Health Enterprises disclosed creation of encumbrance via covenants on 36,90,38,332 shares (27.70% of fully diluted share capital) in favor of Vistra ITCL as debenture trustee for Claypond Capital Partners. Amount involved is INR 500 Crores meant for general corporate purposes, investments, and inter-corporate deposits. Event date 25 August 2026.

Likely market impact

About 27.70% of promoter shares encumbered as security for debentures raised for company corporate purposes. Worth tracking debt servicing.